DE3268699D1 - Derivatives of 4-phenyl-quinazoline active on the central nervous system - Google Patents

Derivatives of 4-phenyl-quinazoline active on the central nervous system

Info

Publication number
DE3268699D1
DE3268699D1 DE8282401905T DE3268699T DE3268699D1 DE 3268699 D1 DE3268699 D1 DE 3268699D1 DE 8282401905 T DE8282401905 T DE 8282401905T DE 3268699 T DE3268699 T DE 3268699T DE 3268699 D1 DE3268699 D1 DE 3268699D1
Authority
DE
Germany
Prior art keywords
phenyl
derivatives
nervous system
central nervous
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282401905T
Other languages
English (en)
Inventor
Kathleen Biziere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of DE3268699D1 publication Critical patent/DE3268699D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
DE8282401905T 1981-10-21 1982-10-18 Derivatives of 4-phenyl-quinazoline active on the central nervous system Expired DE3268699D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8119767A FR2514765A1 (fr) 1981-10-21 1981-10-21 Nouveaux derives de la phenyl-4 quinazoline actifs sur le systeme nerveux central

Publications (1)

Publication Number Publication Date
DE3268699D1 true DE3268699D1 (en) 1986-03-06

Family

ID=9263248

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282401905T Expired DE3268699D1 (en) 1981-10-21 1982-10-18 Derivatives of 4-phenyl-quinazoline active on the central nervous system

Country Status (24)

Country Link
US (1) US4499092A (de)
EP (1) EP0079810B1 (de)
JP (1) JPS5888369A (de)
KR (1) KR880001077B1 (de)
AT (1) ATE17576T1 (de)
AU (1) AU551938B2 (de)
CA (1) CA1236102A (de)
CS (1) CS229692B2 (de)
DD (1) DD210040A5 (de)
DE (1) DE3268699D1 (de)
DK (1) DK156063C (de)
ES (1) ES8307226A1 (de)
FI (1) FI73982C (de)
FR (1) FR2514765A1 (de)
GR (1) GR76535B (de)
HU (1) HU187579B (de)
IE (1) IE53653B1 (de)
IL (1) IL66960A0 (de)
NO (1) NO164167C (de)
NZ (1) NZ202237A (de)
PT (1) PT75667B (de)
SU (1) SU1299511A3 (de)
YU (1) YU43528B (de)
ZA (1) ZA827516B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521144A1 (fr) * 1982-02-08 1983-08-12 Sanofi Sa Nouveaux derives de la piperazinyl-2 phenyl-4 quinazoline possedant des proprietes antidepressives, methode de preparation desdits composes et medicaments en contenant
EP0664128A4 (de) * 1992-10-07 1997-12-17 Sumitomo Pharma Pharmazeutisches mittel zur hemmung der tumornekrosefaktorproduktion.
JPH11209350A (ja) 1998-01-26 1999-08-03 Eisai Co Ltd 含窒素複素環誘導体およびその医薬
ATE372324T1 (de) * 2003-04-30 2007-09-15 Inst For Pharm Discovery Inc Substituierte heteroarylverbindungen als inhibitoren von proteintyrosinphosphatasen
CA2543710A1 (en) * 2003-11-03 2005-05-12 Warner-Lambert Company Llc Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
AU2006263924A1 (en) 2005-06-27 2007-01-04 F. Hoffmann-La Roche Ag Chloro-substituted guanidines
US7855194B2 (en) 2006-03-27 2010-12-21 Hoffmann-La Roche Inc. Pyrimidine, quinazoline, pteridine and triazine derivatives
RU2477046C2 (ru) 2006-11-22 2013-03-10 Сумитомо Кемикал Компани, Лимитед Агент для ингибирования сигнальной функции цитокинина

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA894239A (en) * 1972-02-29 Pfizer Inc. Nitrogen heterocycles
US3305553A (en) * 1965-10-18 1967-02-21 Parke Davis & Co 2-aminoquinazoline derivatives
US3509141A (en) * 1966-09-15 1970-04-28 Ciba Geigy Corp 2-amino-quinazolines
GB1347493A (en) * 1971-02-11 1974-02-27 Aspro Nicholas Ltd Benzazine derivatives
JPS5398997A (en) * 1977-02-09 1978-08-29 Sumitomo Chem Co Ltd Fused pyridine derivertives and process for their preparation

Also Published As

Publication number Publication date
FI823580L (fi) 1983-04-22
JPS5888369A (ja) 1983-05-26
AU551938B2 (en) 1986-05-15
US4499092A (en) 1985-02-12
FR2514765A1 (fr) 1983-04-22
FI823580A0 (fi) 1982-10-20
AU8962882A (en) 1983-04-28
YU43528B (en) 1989-08-31
DK156063B (da) 1989-06-19
EP0079810A1 (de) 1983-05-25
HU187579B (en) 1986-01-28
EP0079810B1 (de) 1986-01-22
ATE17576T1 (de) 1986-02-15
CS229692B2 (en) 1984-06-18
IE53653B1 (en) 1989-01-04
NO823491L (no) 1983-04-22
PT75667B (fr) 1985-01-11
NO164167C (no) 1990-09-05
IL66960A0 (en) 1983-02-23
FI73982C (fi) 1987-12-10
DK465182A (da) 1983-04-22
NO164167B (no) 1990-05-28
SU1299511A3 (ru) 1987-03-23
ZA827516B (en) 1983-08-31
DK156063C (da) 1989-11-13
FI73982B (fi) 1987-08-31
IE822447L (en) 1983-04-21
ES516694A0 (es) 1983-07-01
KR840001968A (ko) 1984-06-07
PT75667A (fr) 1982-11-01
ES8307226A1 (es) 1983-07-01
CA1236102A (en) 1988-05-03
NZ202237A (en) 1985-08-30
DD210040A5 (de) 1984-05-30
FR2514765B1 (de) 1984-04-06
GR76535B (de) 1984-08-10
YU223382A (en) 1984-10-31
KR880001077B1 (ko) 1988-06-22

Similar Documents

Publication Publication Date Title
HUT50786A (en) Process for producing new condensed heterocyclic compounds and pharmaceutical compositions containing them as active components
DE3366141D1 (en) 1-phenylisoquinoline derivatives, process for their preparation, pharmaceutical compositions containing these compounds and their use
AU3923789A (en) Diorganopolysiloxane derivatives, their preparation and their use
ES8207532A1 (es) Procedimiento para la preparacion de xantinas di- o tri- substituidas
DE3268699D1 (en) Derivatives of 4-phenyl-quinazoline active on the central nervous system
IL87490A0 (en) Pharmaceutical compositions containing 2-pyrimidinyl-1-piperazine derivatives for the treatment of alcoholism
ZA836663B (en) Isoquinoline derivatives,a process for their preparation,pharmaceutical formulations based on these compounds and the use thereof
IE56209B1 (en) Piperidinedione derivatives,processing anti-arrythmic activity,for protecting the myocardium,process for their preparation and pharmaceutical compositions containing said derivatives
EP0234348A3 (en) N-glycosyl amide derivatives, method for their preparation and their use as medicaments
IL95166A0 (en) Renin-inhibiting amino oligohydroxy derivatives
ES8800924A1 (es) Procedimiento para la obtencion de benzotiopiranonas
IL87198A0 (en) Leukotriene antagonists,a process for the preparation thereof and pharmaceutical compositions containing them
ES8800666A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina
ES8606298A1 (es) 1.4-dihidropirazinas
IL105599A0 (en) Enantiomers derived from(s)-2-amino-2(3,4-dichlorobenzyl)-1-propanol and pharmaceutical compositions containing same
GR3022125T3 (en) Process for the preparation of 1,3-dialkyl-5-hydroxyoxindoles and of their ether derivatives
KR900014372A (ko) 티에닐피페라진 이의 제조방법 및 이를 함유하는 약제

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee